Xiaoqun Li

2.2k total citations
64 papers, 1.6k citations indexed

About

Xiaoqun Li is a scholar working on Molecular Biology, Surgery and Hepatology. According to data from OpenAlex, Xiaoqun Li has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Surgery and 10 papers in Hepatology. Recurrent topics in Xiaoqun Li's work include Bone Metabolism and Diseases (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Additive Manufacturing Materials and Processes (8 papers). Xiaoqun Li is often cited by papers focused on Bone Metabolism and Diseases (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Additive Manufacturing Materials and Processes (8 papers). Xiaoqun Li collaborates with scholars based in China, Russia and United Kingdom. Xiaoqun Li's co-authors include Jiacan Su, Xiao Chen, Yan Hu, Weizong Weng, Liehu Cao, Jin Cui, Xin Zhi, Jiawei Guo, Hongyuan Song and Yingying Jing and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and ACS Nano.

In The Last Decade

Xiaoqun Li

56 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoqun Li China 22 979 350 254 254 252 64 1.6k
Weihua Xu China 23 705 0.7× 427 1.2× 316 1.2× 191 0.8× 212 0.8× 84 1.8k
Zhiyi Zhou China 23 1.0k 1.1× 154 0.4× 214 0.8× 296 1.2× 282 1.1× 61 1.9k
Xiaolong Xu China 23 1.1k 1.1× 514 1.5× 126 0.5× 122 0.5× 286 1.1× 83 1.9k
Angela De Luca Italy 25 1.0k 1.1× 587 1.7× 127 0.5× 279 1.1× 333 1.3× 71 1.8k
Liangjun Yin China 20 848 0.9× 267 0.8× 115 0.5× 110 0.4× 157 0.6× 59 1.7k
Qiushi Wei China 20 666 0.7× 260 0.7× 477 1.9× 155 0.6× 214 0.8× 107 1.6k
Jia Cao China 19 1.6k 1.6× 544 1.6× 145 0.6× 175 0.7× 120 0.5× 35 2.2k
Hengwei Zhang China 23 1.1k 1.1× 271 0.8× 164 0.6× 133 0.5× 457 1.8× 83 1.9k
Weihua Yu China 28 998 1.0× 385 1.1× 89 0.4× 243 1.0× 276 1.1× 68 2.1k
Kenjiro Bandow Japan 20 746 0.8× 186 0.5× 157 0.6× 208 0.8× 271 1.1× 56 1.5k

Countries citing papers authored by Xiaoqun Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoqun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqun Li more than expected).

Fields of papers citing papers by Xiaoqun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoqun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqun Li. The network helps show where Xiaoqun Li may publish in the future.

Co-authorship network of co-authors of Xiaoqun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoqun Li. A scholar is included among the top collaborators of Xiaoqun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoqun Li. Xiaoqun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Yongchao, et al.. (2025). Microstructure and property evolution in Fe-Cr-Ni alloys with varying Cr content fabricated by laser powder bed fusion. Materials Today Communications. 46. 112494–112494.
2.
4.
Li, Xiaoqun, et al.. (2024). Research progress in CALPHAD assisted metal additive manufacturing. China Foundry. 21(4). 295–310. 1 indexed citations
5.
6.
Ma, Qiang, et al.. (2024). Development of a machine learning model for predicting pneumothorax risk in coaxial core needle biopsy (≤3 cm). European Journal of Radiology. 176. 111508–111508. 1 indexed citations
7.
Zhang, Hao, et al.. (2024). High throughput in-situ synthesis of Fe-Cr-Ni alloys via laser powder bed fusion: Exploring the microstructure and property evolution. Additive manufacturing. 81. 103996–103996. 8 indexed citations
8.
Liu, Han, Hao Zhang, Sicheng Wang, et al.. (2023). Bone-targeted bioengineered bacterial extracellular vesicles delivering siRNA to ameliorate osteoporosis. Composites Part B Engineering. 255. 110610–110610. 64 indexed citations
10.
Wang, Jian, Xiaoqun Li, Sicheng Wang, et al.. (2023). Bone‐Targeted Exosomes: Strategies and Applications. Advanced Healthcare Materials. 12(18). e2203361–e2203361. 61 indexed citations
11.
Hu, Yan, Xiaoqun Li, Xin Zhi, et al.. (2021). RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss. EMBO Reports. 22(7). e52481–e52481. 102 indexed citations
12.
Hu, Yan, Xiaoqun Li, Qin Zhang, et al.. (2021). Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss. Bioactive Materials. 6(9). 2905–2913. 175 indexed citations
13.
Li, Xiaoqun, et al.. (2021). Corylin inhibits osteoclastogenesis and attenuates postmenopausal osteoporosis in mice. Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu. 25(2). 186. 1 indexed citations
14.
Gu, Yanqiu, Xiao Chen, Xiao Chen, et al.. (2020). Development of 3-mercaptopropyltrimethoxysilane (MPTS)-modified bone marrow mononuclear cell membrane chromatography for screening anti-osteoporosis components from Scutellariae Radix. Acta Pharmaceutica Sinica B. 10(10). 1856–1865. 41 indexed citations
15.
Chen, Huiwen, Chao Fang, Xin Zhi, et al.. (2020). Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling‐mediated TRAF6 and c‐Src recruitment and NF‐κB, MAPK and Akt pathways. Journal of Cellular and Molecular Medicine. 24(16). 9067–9084. 56 indexed citations
16.
Li, Xiaoqun, Lipeng Wang, Biaotong Huang, et al.. (2020). Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss. Science Advances. 6(47). 77 indexed citations
17.
Cui, Jin, Xiaoqun Li, Sicheng Wang, et al.. (2020). Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K‐AKT‐NFATc1 pathway. Journal of Cellular and Molecular Medicine. 24(11). 6149–6161. 40 indexed citations
18.
Zhi, Xin, Lipeng Wang, Huiwen Chen, et al.. (2019). l‐tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK‐TRAF6 interactions and inhibiting NF‐κB and MAPK pathways. Journal of Cellular and Molecular Medicine. 24(1). 785–798. 30 indexed citations
19.
Song, Hongyuan, Xiaoqun Li, Qian Jin, et al.. (2019). Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes. Nano Letters. 19(5). 3040–3048. 247 indexed citations
20.
Weng, Weizong, Sisi He, Hongyuan Song, et al.. (2018). Aligned Carbon Nanotubes Reduce Hypertrophic Scar via Regulating Cell Behavior. ACS Nano. 12(8). 7601–7612. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026